Qualified injectors use only approved products and follow safety protocols rigorously, minimizing risks of complications
Recent research presented at The Menopause Societys 2025 Annual Meeting strengthens what we see in our clinics every day
At this point, special attention can be laid on prebiotics and probiotics in ameliorating obesity and T2DM by positively modulating gut peptide production, in particular, GLP-1 [294,299]
Eligibility is based on BMI and clinical criteria, not the BMI 40 commercial threshold
Overall, tolerability appears consistent with other incretin-based therapies, though the triple agonist mechanism introduces a broader physiological effect profile
The MHRA and NHS have expressed concern about the rising trend of individuals obtaining GLP-1 receptor agonists through unregulated online sources or private prescribing services without proper medical assessment